114 related articles for article (PubMed ID: 17297440)
1. PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion.
Liu X; Hu Y; Hao C; Rempel SA; Ye K
Oncogene; 2007 Jul; 26(34):4918-27. PubMed ID: 17297440
[TBL] [Abstract][Full Text] [Related]
2. PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.
Ahn JY; Hu Y; Kroll TG; Allard P; Ye K
Proc Natl Acad Sci U S A; 2004 May; 101(18):6993-8. PubMed ID: 15118108
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide-3-Kinase Enhancers, PIKEs: Their Biological Functions and Roles in Cancer.
Jia W; Feng YI; Sanders AJ; Davies EL; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1103-9. PubMed ID: 26977005
[TBL] [Abstract][Full Text] [Related]
4. M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A.
Werden SJ; Barrett JW; Wang G; Stanford MM; McFadden G
J Virol; 2007 Mar; 81(5):2340-8. PubMed ID: 17151107
[TBL] [Abstract][Full Text] [Related]
5. PIKE/nuclear PI 3-kinase signaling in preventing programmed cell death.
Ye K
J Cell Biochem; 2005 Oct; 96(3):463-72. PubMed ID: 16088938
[TBL] [Abstract][Full Text] [Related]
6. PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion.
Ahn JY; Rong R; Kroll TG; Van Meir EG; Snyder SH; Ye K
J Biol Chem; 2004 Apr; 279(16):16441-51. PubMed ID: 14761976
[TBL] [Abstract][Full Text] [Related]
7. Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-activating Akt, preventing its apoptotic cleavage and promoting cell survival.
Tang X; Feng Y; Ye K
Cell Death Differ; 2007 Feb; 14(2):368-77. PubMed ID: 16841086
[TBL] [Abstract][Full Text] [Related]
8. PIKE GTPase signaling and function.
Ahn JY; Ye K
Int J Biol Sci; 2005; 1(2):44-50. PubMed ID: 15951849
[TBL] [Abstract][Full Text] [Related]
9. Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation.
Qi Q; He K; Liu X; Pham C; Meyerkord C; Fu H; Ye K
Oncogene; 2013 Feb; 32(8):1030-40. PubMed ID: 22450747
[TBL] [Abstract][Full Text] [Related]
10. The roles of PIKE in tumorigenesis.
Qi Q; Ye K
Acta Pharmacol Sin; 2013 Aug; 34(8):991-7. PubMed ID: 23770988
[TBL] [Abstract][Full Text] [Related]
11. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
12. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.
Knobbe CB; Trampe-Kieslich A; Reifenberger G
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):486-90. PubMed ID: 16150119
[TBL] [Abstract][Full Text] [Related]
13. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
14. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings.
Hu Y; Liu Z; Ye K
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16853-8. PubMed ID: 16263930
[TBL] [Abstract][Full Text] [Related]
17. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion.
Liu R; Tian B; Gearing M; Hunter S; Ye K; Mao Z
Proc Natl Acad Sci U S A; 2008 May; 105(21):7570-5. PubMed ID: 18487454
[TBL] [Abstract][Full Text] [Related]
18. Akt-phosphorylated PIKE-A inhibits UNC5B-induced apoptosis in cancer cell lines in a p53-dependent manner.
He K; Jang SW; Joshi J; Yoo MH; Ye K
Mol Biol Cell; 2011 Jun; 22(11):1943-54. PubMed ID: 21460185
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
